| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-20 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-06 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |